1. Home
  2. GNPX vs NWTG Comparison

GNPX vs NWTG Comparison

Compare GNPX & NWTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • NWTG
  • Stock Information
  • Founded
  • GNPX 2009
  • NWTG 2018
  • Country
  • GNPX United States
  • NWTG United States
  • Employees
  • GNPX N/A
  • NWTG N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • NWTG Recreational Games/Products/Toys
  • Sector
  • GNPX Health Care
  • NWTG Consumer Discretionary
  • Exchange
  • GNPX Nasdaq
  • NWTG Nasdaq
  • Market Cap
  • GNPX 7.4M
  • NWTG 8.5M
  • IPO Year
  • GNPX 2018
  • NWTG N/A
  • Fundamental
  • Price
  • GNPX $0.17
  • NWTG $1.76
  • Analyst Decision
  • GNPX
  • NWTG
  • Analyst Count
  • GNPX 0
  • NWTG 0
  • Target Price
  • GNPX N/A
  • NWTG N/A
  • AVG Volume (30 Days)
  • GNPX 6.3M
  • NWTG 148.0K
  • Earning Date
  • GNPX 08-14-2025
  • NWTG 08-14-2025
  • Dividend Yield
  • GNPX N/A
  • NWTG N/A
  • EPS Growth
  • GNPX N/A
  • NWTG N/A
  • EPS
  • GNPX N/A
  • NWTG N/A
  • Revenue
  • GNPX N/A
  • NWTG $5,560,000.00
  • Revenue This Year
  • GNPX N/A
  • NWTG $98.37
  • Revenue Next Year
  • GNPX N/A
  • NWTG $49.25
  • P/E Ratio
  • GNPX N/A
  • NWTG N/A
  • Revenue Growth
  • GNPX N/A
  • NWTG 304.36
  • 52 Week Low
  • GNPX $0.14
  • NWTG $1.35
  • 52 Week High
  • GNPX $3.97
  • NWTG $119.10
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 35.07
  • NWTG 50.89
  • Support Level
  • GNPX $0.14
  • NWTG $1.48
  • Resistance Level
  • GNPX $0.25
  • NWTG $1.80
  • Average True Range (ATR)
  • GNPX 0.02
  • NWTG 0.19
  • MACD
  • GNPX -0.01
  • NWTG -0.03
  • Stochastic Oscillator
  • GNPX 23.78
  • NWTG 37.43

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About NWTG Newton Golf Company Inc. Common Stock

Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

Share on Social Networks: